Mar. Drugs 2010, 8(6), 1769-1778; https://doi.org/10.3390/md8061769
Evaluation of Pyridoacridine Alkaloids in a Zebrafish Phenotypic Assay
1
Department of Medicinal Chemistry, University of Utah, Salt Lake City, UT 84112, USA
2
Department of Oncological Sciences, Huntsman Cancer Institute, 2000 Circle of Hope, Salt Lake City, UT 84112, USA
*
Author to whom correspondence should be addressed.
Received: 28 April 2010 / Revised: 20 May 2010 / Accepted: 25 May 2010 / Published: 2 June 2010
(This article belongs to the Special Issue Marine Alkaloids)
View Full-Text
|
Download PDF [190 KB, uploaded 24 February 2015]
Abstract
Three new minor components, the pyridoacridine alkaloids 1-hydroxy-deoxyamphimedine (1), 3-hydroxy-deoxyamphimedine (2), debromopetrosamine (3), and three known compounds, amphimedine (4), neoamphimedine (5) and deoxyamphimedine (6), have been isolated from the sponge Xestospongia cf. carbonaria, collected in Palau. Structures were assigned on the basis of extensive 1D and 2D NMR studies as well as analysis by HRESIMS. Compounds 1–6 were evaluated in a zebrafish phenotype-based assay. Amphimedine (4) was the only compound that caused a phenotype in zebrafish embryos at 30 µM. No phenotype other than death was observed for compounds 1–3, 5, 6. View Full-Text
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).
Share & Cite This Article
MDPI and ACS Style
Wei, X.; Bugni, T.S.; Harper, M.K.; Sandoval, I.T.; Manos, E.J.; Swift, J.; Van Wagoner, R.M.; Jones, D.A.; Ireland, C.M. Evaluation of Pyridoacridine Alkaloids in a Zebrafish Phenotypic Assay. Mar. Drugs 2010, 8, 1769-1778.
Related Articles
Article Metrics
Comments
[Return to top]
Mar. Drugs
EISSN 1660-3397
Published by MDPI AG, Basel, Switzerland
RSS
E-Mail Table of Contents Alert